ECSP993206A - METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR - Google Patents
METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIRInfo
- Publication number
- ECSP993206A ECSP993206A ECSP993206A ECSP993206A EC SP993206 A ECSP993206 A EC SP993206A EC SP993206 A ECSP993206 A EC SP993206A EC SP993206 A ECSP993206 A EC SP993206A
- Authority
- EC
- Ecuador
- Prior art keywords
- tipranavir
- pharmacokinetics
- improve
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- SUJUHGSWHZTSEU-UHFFFAOYSA-N Tipranavir Natural products C1C(O)=C(C(CC)C=2C=C(NS(=O)(=O)C=3N=CC(=CC=3)C(F)(F)F)C=CC=2)C(=O)OC1(CCC)CCC1=CC=CC=C1 SUJUHGSWHZTSEU-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000838 tipranavir Drugs 0.000 title abstract 3
- SUJUHGSWHZTSEU-FYBSXPHGSA-N tipranavir Chemical compound C([C@@]1(CCC)OC(=O)C([C@H](CC)C=2C=C(NS(=O)(=O)C=3N=CC(=CC=3)C(F)(F)F)C=CC=2)=C(O)C1)CC1=CC=CC=C1 SUJUHGSWHZTSEU-FYBSXPHGSA-N 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960000311 ritonavir Drugs 0.000 abstract 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con nuevo método para mejorar la farmacocinética del tipranavir; que consiste en administrar una combianción de una cantidad terapéuticamente eficaz de tipranavir o una sal farmacéuticamente aceptable del mismo, y una cantidad terapéuticamente eficaz de ritonavir o una sal farmacéuticamente aceptable del mismo, a un humano que necesita de dicho tratamiento.The present invention relates to a new method to improve the pharmacokinetics of tipranavir; consisting of administering a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of ritonavir or a pharmaceutically acceptable salt thereof, to a human in need of such treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993206 ECSP993206A (en) | 1999-11-04 | 1999-11-04 | METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993206 ECSP993206A (en) | 1999-11-04 | 1999-11-04 | METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993206A true ECSP993206A (en) | 2000-03-22 |
Family
ID=42044194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993206 ECSP993206A (en) | 1999-11-04 | 1999-11-04 | METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993206A (en) |
-
1999
- 1999-11-04 EC ECSP993206 patent/ECSP993206A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| CA2426703A1 (en) | Therapeutic agents and methods of use thereof for the modulation of angiogenesis | |
| DK1289517T3 (en) | Pharmaceutical compositions containing cannabidiol derivatives | |
| WO2002043652A3 (en) | Anti-proliferative drugs | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| IS4972A (en) | Use of the chelating agent clioquinol in the manufacture of a pharmaceutical composition for the treatment of Alzheimer's disease | |
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
| GB0008269D0 (en) | Combination chemotherapy | |
| WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
| CY1109191T1 (en) | A NEW USE OF DIFFERIPRON | |
| CL2008003938A1 (en) | Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00). | |
| GB2368525A (en) | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| WO2000072823A8 (en) | Preparations for the application of anti-inflammatory agents | |
| WO2003092608A3 (en) | Methionine aminopeptidase-2 inhibitors and methods of use thereof | |
| UA87877C2 (en) | Pegylated liposomal doxorubicin in combination with ecteinescidin 743 | |
| AU7862401A (en) | Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer | |
| WO2001045715A3 (en) | Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| EE200100689A (en) | Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition | |
| ECSP993206A (en) | METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR | |
| AR030660A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds |